Sjs Investment Consulting Inc. Bausch Health Companies Inc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q3 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 30 shares of BHC stock, worth $245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$245
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.96B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...